Publications by authors named "Maria Carla Tablante"

Introduction: Diagnostic and therapeutic methods for colorectal cancer (CRC) have advanced; however, they may be inaccessible worldwide, and their widespread use is challenging. This questionnaire survey investigates the current status of diagnosis and treatment of early-stage CRC in Asian countries.

Methods: Responses to the questionnaire were obtained from 213 doctors at different institutions in 8 countries and regions.

View Article and Find Full Text PDF
Article Synopsis
  • The COVID-19 pandemic led to a sharp decline in gastrointestinal (GI) endoscopy services across several Asian countries, attributed to reduced patient attendance and strict adherence to safety guidelines.
  • A survey involving 166 healthcare professionals highlighted that procedures like endoscopic screenings and follow-ups were significantly postponed, resulting in delayed cancer diagnoses and exacerbated GI conditions.
  • Safety measures during endoscopy included the use of extensive personal protective equipment and modifications to patient equipment, but educational and research activities within the field saw a decrease during this period.
View Article and Find Full Text PDF

Background: Second-generation colon capsule endoscopy (CCE-2) has been reported as a potential tool for monitoring ulcerative colitis (UC). However, its excretion rate is still unsatisfactory, and the bowel preparation regimen is not well tolerated. Furthermore, a standard bowel preparation regimen validated for UC has not been established.

View Article and Find Full Text PDF

Extracolonic involvement of the gastrointestinal tract is extremely uncommon in ulcerative colitis (UC) and rarely found in the upper gastrointestinal tract or in postoperative cases since it typically responds to steroids. Here we report a case of UC complicated by extensive ileal inflammation that was refractory to steroids. A 20-year-old man was diagnosed with UC of typical pancolitis without ileal involvement and started treatment with pH-dependent mesalazine and oral prednisolone.

View Article and Find Full Text PDF